From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiology

The author happened to be involved in the discovery and assessment of biological therapies, which are otherwise uncommon in the field of cardiology. Thus, he has the opportunity to draw some conclusions from his experience and, at the same time, shed light on instructive research dead ends and failu...

Full description

Saved in:
Bibliographic Details
Main Author: Róbert Gábor Kiss
Format: Article
Language:English
Published: Promenade Kft 2025-07-01
Series:Cardiologia Hungarica
Subjects:
Online Access:https://cardiologia.hungarica.eu/archive/2025-issues/2025-3-contents/from-abciximab-to-abelacimab-subjective-surfing-upon-discoveries-and-fiascos-of-biological-therapies-in-cardiology
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849728947971948544
author Róbert Gábor Kiss
author_facet Róbert Gábor Kiss
author_sort Róbert Gábor Kiss
collection DOAJ
description The author happened to be involved in the discovery and assessment of biological therapies, which are otherwise uncommon in the field of cardiology. Thus, he has the opportunity to draw some conclusions from his experience and, at the same time, shed light on instructive research dead ends and failures.
format Article
id doaj-art-cb83a3bb48c14c648aca448680c84316
institution DOAJ
issn 0133-5596
1588-0230
language English
publishDate 2025-07-01
publisher Promenade Kft
record_format Article
series Cardiologia Hungarica
spelling doaj-art-cb83a3bb48c14c648aca448680c843162025-08-20T03:09:24ZengPromenade KftCardiologia Hungarica0133-55961588-02302025-07-0155315916110.26430/CHUNGARICA.2025.55.3.159From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiologyRóbert Gábor Kiss0North Pest Central Hospital - Honvéd Hospital, BudapestThe author happened to be involved in the discovery and assessment of biological therapies, which are otherwise uncommon in the field of cardiology. Thus, he has the opportunity to draw some conclusions from his experience and, at the same time, shed light on instructive research dead ends and failures.https://cardiologia.hungarica.eu/archive/2025-issues/2025-3-contents/from-abciximab-to-abelacimab-subjective-surfing-upon-discoveries-and-fiascos-of-biological-therapies-in-cardiologyantitrombotics
spellingShingle Róbert Gábor Kiss
From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiology
Cardiologia Hungarica
antitrombotics
title From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiology
title_full From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiology
title_fullStr From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiology
title_full_unstemmed From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiology
title_short From abciximab to abelacimab. Subjective surfing upon discoveries and fiascos of biological therapies in cardiology
title_sort from abciximab to abelacimab subjective surfing upon discoveries and fiascos of biological therapies in cardiology
topic antitrombotics
url https://cardiologia.hungarica.eu/archive/2025-issues/2025-3-contents/from-abciximab-to-abelacimab-subjective-surfing-upon-discoveries-and-fiascos-of-biological-therapies-in-cardiology
work_keys_str_mv AT robertgaborkiss fromabciximabtoabelacimabsubjectivesurfingupondiscoveriesandfiascosofbiologicaltherapiesincardiology